Log In
Print
BCIQ
Print
Print this Print this
 

ADX-N05, ARL-N05, SKL-N05

  Manage Alerts
Collapse Summary General Information
Company SK Biopharmaceuticals Co. Ltd.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationExcessive sleepiness
Indication DetailsTreat excessive daytime sleepiness (EDS) in patients with narcolepsy
Regulatory Designation

Partner

Aerial BioPharma LLC; Jazz Pharmaceuticals plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today